Specific activation of human mast cells by the ligand for c-kit: comparison between lung, uterus and heart mast cells. 1993

W R Sperr, and K Czerwenka, and G Mundigler, and M R Müller, and H Semper, and G Klappacher, and H D Glogar, and K Lechner, and P Valent
Department of Internal Medicine I, University of Vienna, Austria.

Recent data suggest that stem cell factor (SCF or c-kit ligand, KL) is a major regulator of human mast cells (MCs). In the present study, MCs derived from the lung (n = 8), uterus (n = 14) and heart (n = 4) were analyzed for expression of c-kit receptor and for responses to recombinant SCF. MCs of all organs tested were recognized by mAbs to c-kit (YB5.B8, SR-1) as assessed by combined toluidine blue/immunofluorescence staining. Activation by rhSCF (10 ng/ml, 60 min) resulted in histamine release from lung MCs (SCF 12.8 +/- 2.7% histamine release; control 2.8 +/- 0.8%, p < 0.01), uterus MCs (SCF 16.8 +/- 5.8%; control 5.2 +/- 2.5%, p < 0.01) and heart MCs (SCF 18.4 +/- 2.6%; control 1.7 +/- 0.23%, p < 0.01). Short-term pre-incubation with rhSCF (15 min) did not result in histamine secretion (p > 0.05), but in an increase (lung 2.4 +/- 1.0 fold; uterus 2.1 +/- 1.1 fold, and heart 2.0 +/- 0.4 fold) of alpha IgE-induced mediator release (p < 0.05). The effects of SCF were dose-dependent (maximum responses at 10-100 ng/ml) and dependent on extracellular calcium. A monoclonal antibody to SCF was found to inhibit the effects of SCF on MCs. Furthermore, MCs could be desensitized specifically by pre-incubation of MCs with rhSCF in Ca-free medium. Together, these data suggest that SCF triggers mediator secretion from MCs in various organs via binding to the c-kit receptor.

UI MeSH Term Description Entries
D007073 Immunoglobulin E An immunoglobulin associated with MAST CELLS. Overexpression has been associated with allergic hypersensitivity (HYPERSENSITIVITY, IMMEDIATE). IgE
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008297 Male Males
D008407 Mast Cells Granulated cells that are found in almost all tissues, most abundantly in the skin and the gastrointestinal tract. Like the BASOPHILS, mast cells contain large amounts of HISTAMINE and HEPARIN. Unlike basophils, mast cells normally remain in the tissues and do not circulate in the blood. Mast cells, derived from the bone marrow stem cells, are regulated by the STEM CELL FACTOR. Basophils, Tissue,Basophil, Tissue,Cell, Mast,Cells, Mast,Mast Cell,Tissue Basophil,Tissue Basophils
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D011518 Proto-Oncogene Proteins Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. Cellular Proto-Oncogene Proteins,c-onc Proteins,Proto Oncogene Proteins, Cellular,Proto-Oncogene Products, Cellular,Cellular Proto Oncogene Proteins,Cellular Proto-Oncogene Products,Proto Oncogene Products, Cellular,Proto Oncogene Proteins,Proto-Oncogene Proteins, Cellular,c onc Proteins
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D003888 Desensitization, Immunologic Immunosuppression by the administration of increasing doses of antigen. Though the exact mechanism is not clear, the therapy results in an increase in serum levels of allergen-specific IMMUNOGLOBULIN G, suppression of specific IgE, and an increase in suppressor T-cell activity. Allergen Immunotherapy,Allergy Shots,Hyposensitization Therapy,Immunotherapy, Allergen,Venom Immunotherapy,Immunologic Desensitization,Therapy, Hyposensitization,Allergen Immunotherapies,Allergy Shot,Desensitizations, Immunologic,Hyposensitization Therapies,Immunologic Desensitizations,Immunotherapy, Venom,Shot, Allergy,Venom Immunotherapies
D004306 Dose-Response Relationship, Immunologic A specific immune response elicited by a specific dose of an immunologically active substance or cell in an organism, tissue, or cell. Immunologic Dose-Response Relationship,Relationship, Immunologic Dose-Response,Dose Response Relationship, Immunologic,Dose-Response Relationships, Immunologic,Immunologic Dose Response Relationship,Immunologic Dose-Response Relationships,Relationship, Immunologic Dose Response,Relationships, Immunologic Dose-Response

Related Publications

W R Sperr, and K Czerwenka, and G Mundigler, and M R Müller, and H Semper, and G Klappacher, and H D Glogar, and K Lechner, and P Valent
January 1992, International archives of allergy and immunology,
W R Sperr, and K Czerwenka, and G Mundigler, and M R Müller, and H Semper, and G Klappacher, and H D Glogar, and K Lechner, and P Valent
January 1992, The Journal of experimental medicine,
W R Sperr, and K Czerwenka, and G Mundigler, and M R Müller, and H Semper, and G Klappacher, and H D Glogar, and K Lechner, and P Valent
January 1992, International archives of allergy and immunology,
W R Sperr, and K Czerwenka, and G Mundigler, and M R Müller, and H Semper, and G Klappacher, and H D Glogar, and K Lechner, and P Valent
January 1993, Proceedings of the National Academy of Sciences of the United States of America,
W R Sperr, and K Czerwenka, and G Mundigler, and M R Müller, and H Semper, and G Klappacher, and H D Glogar, and K Lechner, and P Valent
October 1996, Experimental hematology,
W R Sperr, and K Czerwenka, and G Mundigler, and M R Müller, and H Semper, and G Klappacher, and H D Glogar, and K Lechner, and P Valent
January 1992, International archives of allergy and immunology,
W R Sperr, and K Czerwenka, and G Mundigler, and M R Müller, and H Semper, and G Klappacher, and H D Glogar, and K Lechner, and P Valent
December 1997, Blood,
W R Sperr, and K Czerwenka, and G Mundigler, and M R Müller, and H Semper, and G Klappacher, and H D Glogar, and K Lechner, and P Valent
January 1994, International archives of allergy and immunology,
W R Sperr, and K Czerwenka, and G Mundigler, and M R Müller, and H Semper, and G Klappacher, and H D Glogar, and K Lechner, and P Valent
January 1993, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine,
W R Sperr, and K Czerwenka, and G Mundigler, and M R Müller, and H Semper, and G Klappacher, and H D Glogar, and K Lechner, and P Valent
October 2004, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!